CA 125

The CA 125 test measures the level of cancer antigen 125, a protein that may be present in the bloodstream. It is primarily used in the assessment and management of conditions related to the ovaries.

Clinical indications
* Assisting in the evaluation of ovarian cancer
* Monitoring response to treatment in patients with ovarian cancer
* Ongoing follow-up in individuals with a known history of ovarian malignancy

The findings related to these particular clinical tests are a general guide and do not cover every possible scenario, this is because every patient is unique and these results only have true clinical significance when combined with the patient’s full medical history, a physical exam, and other diagnostic findings.

Phlebotomy service fee: £20.